Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tesomet in Prader-Willi Syndrome
NCT05198362Phase 2Withdrawn
- Sponsor
- Saniona
- Start
- Dec 2021
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Tesomet in Prader-Willi syndrome (PWS), sponsored by Saniona. Planned start Dec 2021; status: withdrawn.
02
Drugs
Tesomet
03
Conditions
Prader-Willi syndrome (PWS)
Beyond the preview
Go deeper on NCT05198362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05198362.